Roberta Brinton
Director and Regents Professor, Center for Innovation in Brain Science at the University of Arizona
Dr. Roberta Diaz Brinton leads the Center for Innovation in Brain Science at the University of Arizona, a university research / biotech ecosystem devoted to developing therapeutics for Alzheimer’s, Parkinson’s, Multiple Sclerosis and ALS. She is Regents Professor of Pharmacology, Neuroscience and Neurology at the UArizona College of Medicine - Tucson. Her neuroscience research spans discovery, translational and clinical science, authoring over 250 scientific publications, holds multiple patents and founded 2 biotech start-ups, most recently, NeuTherapeutics. She is an internationally recognized expert on Alzheimer’s whose discoveries have led to innovative therapeutics to prevent, delay, and treat the disease. She is currently conducting three National Institute on Aging Phase 2 clinical trials, including the REGEN-BRAIN© trial to regenerate the Alzheimer’s brain. Brinton serves on the NIH Director’s Advisory Committee, NIA Scientific Advisory Board and Alzheimer’s Drug Discovery Foundation Board of Governors. Her honors include Scientist of the Year from the Alzheimer's Drug Discovery Foundation, Goodes Prize, AZBio Researcher of the Year, and U.S. Presidential Citizens Medal for STEM education.
